Section of Breast Imaging

Medicine & Life Sciences

1. Mammography 100%
2. Breast 99%
3. Biopsy 56%
4. Complement Activation 54%
5. Image-Guided Biopsy 52%
6. Digital Subtraction Angiography 42%
7. Radiologists 38%
8. Breast Neoplasms 34%
9. fluciclovine F-18 32%
10. Complement C3b 31%
11. Allografts 30%
12. Computed Tomography Angiography 30%
13. Monosomy 1p Chromosome 1 28%
14. Neoplasms 28%
15. Informed Consent 27%
16. Extracorporeal Membrane Oxygenation 26%
17. Optical Tomography 26%
18. Isoprostanes 25%
19. Head 25%
20. Phyllodes Tumor 25%
21. Sharks 25%
22. Maximal Respiratory Pressures 24%
23. Gynecomastia 24%
24. Alternative Complement Pathway 24%
25. Muromonab-CD3 23%
26. Fibroadenoma 23%
27. Cerebral Blood Volume 23%
28. Immunoglobulin Heavy Chains 22%
29. Pediatrics 22%
30. Eicosapentaenoic Acid 21%
31. Transplant Recipients 21%
32. Respiratory Muscles 21%
33. Burkitt Lymphoma 21%
34. Nerve Block 20%
35. Appendicitis 19%
36. Hospital Emergency Service 19%
37. Music 19%
38. Health Insurance Portability and Accountability Act 19%
39. Syncope 19%
40. Cerebral Hemorrhage 18%
41. Kidney 18%
42. Heart Transplantation 18%
43. Research Ethics Committees 18%
44. Aspartic Acid 18%
45. Osteosarcoma 18%
46. Thorax 18%
47. Muscle Strength 18%
48. Child 17%
49. Radiology 17%
50. Magnetic Resonance Imaging 17%
51. Pancreatitis 17%
52. Tomography 17%
53. Cyclosporine 16%
54. Glioma 16%
55. Anxiety 16%
56. Fistula 15%
57. Confidence Intervals 15%
58. Arm 15%
59. Neurotransmitter Agents 15%
60. Retina 15%
61. Magnetic Resonance Spectroscopy 14%
62. Retrospective Studies 14%
63. Cattle 14%
64. Angiography 14%
65. Prostatic Neoplasms 13%
66. Ultrasonography 13%
67. Prospective Studies 13%
68. Neck 13%
69. Subclavian Steal Syndrome 13%
70. Perfusion 13%
71. Randomized Controlled Trials 13%
72. Orthopedics 12%
73. Nurses 12%
74. Cost Savings 12%
75. Hemorrhage 11%
76. Data Systems 11%
77. Atherosclerosis 10%
78. Costs and Cost Analysis 10%
79. Vertebral Artery 10%
80. Recurrence 10%
81. Pancreas 10%
82. ROC Curve 10%
83. Radiofrequency Ablation 9%
84. Lung 9%
85. Coracoid Process 9%
86. Nose 8%
87. Acceleration 8%
88. Health 8%
89. ramatroban 8%
90. Prostaglandins 8%
91. Transplants 8%
92. Dibenz(b,f)(1,4)oxazepine-10(11H)-carboxylic acid, 8-chloro-, 2-acetylhydrazide 8%
93. complement C4d 7%
94. Neutrophils 7%
95. Multiple Sclerosis 7%
96. Receptors, Prostaglandin E, EP1 Subtype 7%
97. SQ 29548 7%
98. Therapeutics 7%
99. 6-isopropoxy-9-oxoxanthene-2-carboxylic acid 7%